Skip to main content
. 2021 May 5;28(10):2888–2899. doi: 10.1038/s41418-021-00790-3

Fig. 2. TRIM25 promotes the proteasomal degradation of RIP3.

Fig. 2

a Immunoblotting analysis of RIP1, RIP3, and MLKL in WT and TRIM25 KO HT-29 cells. b FLAG-tagged RIP3 was transfected into HeLa cells, then followed by the treatment with siRNAs of TRIM25. c FLAG-tagged RIP3 was co-transfected with or without Myc-tagged TRIM25 into HeLa cells, followed by the treatment by adding 10 uM MG132. d FLAG-tagged RIP3 was co-transfected with Myc-tagged TRIM25 or its mutant TRIM25CS into HeLa cells, followed by the treatment with adding 10 uM MG132. e TRIM25 or TRIM25CS were co-transfected with RIP3 in a dose-dependent manner in HeLa cells. f FLAG-tagged RIP3 was co-transfected with or without Myc-tagged TRIM25 into HeLa cells, followed by the treatment with MG132 (10 uM) or chloroquine (10 uM) for 4 h.